The current valuation score of HCW Biologics Inc is 9.63, ranking 19 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.30, which is -93.63% below the recent high of -0.02 and -88633.46% above the recent low of -267.35.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.